Prior to Synecor, he served as CEO of M3 Medical and held leadership roles at Globus Medical.
TransEnterix relies on rapid prototyping, intense pre-clinical labs and hands-on collaboration with expert surgeons who provide input into device development to accelerate the company’s learning and allows it to bring a device to market more quickly.
Miller’s job is to integrate prototype improvements in a way that will ensure the final product’s large-scale manufacturability.
“Tom takes big-picture vision and tangible ideas coming from several different sources and turns them into a workable solution that we hope ultimately will end up in the hands of physicians performing minimally invasive surgery,” said Todd M. Pope, president and CEO.
